Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesMesenchymal Stem Cell-Mediated Effects of Tumor Support or SuppressionMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyApplication of platelet-rich plasma with stem cells in bone and periodontal tissue engineeringAC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study.Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancerHuman bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenograftshTERT-Immortalized Bone Mesenchymal Stromal Cells Expressing Rat Galanin via a Single Tetracycline-Inducible Lentivirus SystemTherapeutic potential of genetically modified adult stem cells for osteopenia.Generation and characterization of an immortalized human mesenchymal stromal cell line.Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured.Mesenchymal stem cells as therapeutics and vehicles for gene and drug deliveryPotential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling.Human bone marrow-derived mesenchymal stem cells.Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growthMethionine sulfoxide reductase A (MsrA) protects cultured mouse embryonic stem cells from H2O2-mediated oxidative stress.hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancerThe great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disordersIsolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: the grass is not always green(er)Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effectsThe development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccineBone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!Role of stem cells in cancer therapy and cancer stem cells: a review.The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growthGrowth Inhibitory Effect of Palatine Tonsil-derived Mesenchymal Stem Cells on Head and Neck Squamous Cell Carcinoma Cells.Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcomaThe potential of stem cell therapies for neurological diseases.In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistributionStrategies to achieve systemic delivery of therapeutic cells and microbes to tumors.Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferationStem cells tropism for malignant gliomas.Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy.Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors.Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapySelective delivery of a therapeutic gene for treatment of head and neck squamous cell carcinoma using human neural stem cells.Condition medium of HepG-2 cells induces the transdifferentiation of human umbilical cord mesenchymal stem cells into cancerous mesenchymal stem cells.
P2860
Q26740083-91C355BB-A077-4EE4-B9B4-E1E9D7D9D935Q26773413-A3AD5708-CE24-47A3-B291-BE3F3453163EQ27004205-669AC500-84E3-44F5-89C3-9F6CDE2F23F7Q28076740-FEF2886D-874A-417F-A5CB-1FD33AE3D046Q33423261-A334078E-0B7D-44B5-B1E8-6293704902C9Q33599142-440B6797-2412-4294-A957-6FB45F1E1A80Q33618949-8E8039FB-3020-418A-9A45-ABE7927F39F3Q33726434-0710EF8F-5F1C-4D9A-8307-79677B586E75Q34137317-3AC17F86-1914-42EA-872A-9D938EAD850BQ34231344-33C9255E-1371-468F-8049-898A9787A08DQ34243638-765EE3CE-5984-48BF-B209-968543D8E68BQ34278413-F06CD4FA-28ED-489F-BCB9-B37EBC47C07BQ34349428-DD5070DA-4DC9-440E-96D9-C6ABC8AFADD3Q34367266-09AFA9E2-4925-48FC-9658-92B4B554D745Q34706869-A0192038-CF5D-4F9D-8DDA-E17F7BBF7D86Q34803950-05750F3B-391D-40C7-902C-9DCE670EC4C8Q34811043-ACA67AD3-A057-4488-AF7E-029E332EF127Q35077849-A2DD6560-32F4-4EF0-8874-828DA4BA4267Q35086702-2570E192-5745-4E50-B33B-0D4DF764B757Q35107504-70A82004-4D2D-41C7-A541-2756D45467E9Q35256491-3B1DF691-378D-4B51-9D49-EB9D559910CBQ35296805-BE09273E-7052-474B-B673-652FA486CC75Q35620657-5F5A4F7C-FBF1-45C6-B0C4-FFC15078D88BQ35623444-9A3456ED-0115-4F22-8268-A6ACE0E42E63Q35792838-1A63AEDE-7516-454C-A96B-CA488A9F5220Q35846826-14629278-DE85-49DD-9D75-D7498D389109Q35861681-D0CB36F9-D24C-43A2-8971-2D9603C0B551Q36049190-4F6BDBFE-736C-4089-8461-AFE3444B318FQ36238078-A9D23069-B634-4A8A-81D2-BA97FDE461FEQ36390804-3FBDE1C8-99FE-4574-90E0-073D92F6F536Q36402844-87EE9B9C-919E-4554-A30E-E0C4416A3C59Q36675446-818A0A98-3E56-4713-BB38-5BED2686C773Q36968300-7309FFD0-B0D7-4791-B516-9BA356F86B53Q37026653-D1E51FC6-86F2-4029-8DEF-31A9F1BAC0ABQ37094023-7CD7DBCD-7DCC-4787-A90E-CFB3FB54B645Q37120256-E398161D-89AE-4238-AC08-A4687B5A5CDFQ37134013-B6850A6C-B0D0-47EF-B38B-CD6D99F13379Q37140126-EDB43B82-C20C-444A-9EB2-EAF4E4A6EDF0Q37192753-7C9CCE01-08EE-4E35-B7A5-B49D67D05F78Q37227978-425F2B10-1ABA-407C-A212-DF0B9002FCA9
P2860
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@ast
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@en
type
label
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@ast
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@en
prefLabel
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@ast
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy.
@en
P2093
P2860
P1433
P1476
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy
@en
P2093
Hirofumi Hamada
Kazunori Kato
Kiminori Nakamura
Kiyohiro Houkin
Masayoshi Kobune
Takuya Matsunaga
Yoshiro Niitsu
Yutaka Kawano
P2860
P304
P356
10.1111/J.1349-7006.2005.00032.X
P50
P577
2005-03-01T00:00:00Z